Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751082 · ClinicalTrials.gov registry record
Real World Observational Study of Sotatercept for Pulmonary Hypertension
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 120
- Enrollment target
NCT06751082: Recruiting study, sponsored by Mayo Clinic.
NCT06751082 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06751082 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
Primary Outcome
The EmPHasis10 Questionnaire consists of 10 questions to assess quality of life. The scores can range from 0-50, a higher score indicates a worse quality of life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-01-20 |
| Est. Completion | 2027-03 |
What NCT06751082 shows while recruiting
NCT06751082 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06751082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06751082 about?
NCT06751082 is a clinical study titled "Real World Observational Study of Sotatercept for Pulmonary Hypertension". The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
What is the current status of trial NCT06751082?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-01-20. Estimated completion is 2027-03.
Who is sponsoring clinical trial NCT06751082?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI